Recent research trials surrounding Retatrutide , specifically the 120mg formulation referred to as ZPHC, suggest a impressive impact on body mass reduction and associated health conditions . Scientists anticipate that this combined compound, targeting both GLP-1 and GIP systems, could offer a substantial improvement in the management of obesity and